Financhill
Back

ADC Therapeutics SA 10K Form

Sell
40

ADCT
ADC Therapeutics SA

Last Price:
$3.16
Seasonality Move:
-27.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADCT News And Ratings

See the #1 stock for the next 7 days that we like better than ADCT

ADCT Financial Statistics

Sales & Book Value

Annual Sales: $70.8M
Cash Flow: $-56.6M
Price / Cash Flow: 0
Annual Sales: $-2.40
Price / Book: 0

Profitability

EPS (TTM): -1.45000
Net Income (TTM): $-149.8M
Gross Margin: $64.9M
Return on Equity: 0%
Return on Assets: -46.15%

ADC Therapeutics SA Earnings Forecast

Key ADC Therapeutics SA Financial Ratios

  • The Gross Profit Margin over the past 6 years for ADCT is 91.60%.
  • The Selling, General & Administrative Expenses for ADCT have been equal to 121.28% of Gross Profit Margin.
  • The Research & Development expenses have been 154.77% of Revenue.
  • The Net Earning history of ADCT is -222.83% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

ADC Therapeutics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADCT
CUSIP: H0036K
Website: adctherapeutics.com

Debt

Debt-to-Equity Ratio: -0.48
Current Ratio: 4.46
Quick Ratio: 3.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADCT Technical Analysis vs Fundamental Analysis

Sell
40
ADC Therapeutics SA (ADCT) is a Sell

Is ADC Therapeutics SA a Buy or a Sell?